Literature DB >> 21475697

Ethical guidelines for authorship and publishing in the Journal of Cachexia, Sarcopenia and Muscle.

Stephan von Haehling, John E Morley, Andrew J S Coats, Stefan D Anker.   

Abstract

The principles of ethical authorship and publishing in the Journal of Cachexia, Sarcopenia and Muscle (JCSM) are: all authors listed on the manuscript have approved its submission and publication as provided to JCSM;no person who has a right to be recognized as author has been omitted from the list of authors;each author has made an independent material contribution to the work submitted for publication;the submitted work is original and is neither under consideration elsewhere nor has it been published previously in whole or in part other than in abstract form;all original research work is approved by the relevant bodies such as institutional review boards or ethics committees;all conflicts of interest, financial or otherwise, that may affect the authors' ability to present data objectively have been duly declared in the manuscript;the manuscript in its published form will be maintained on the servers of JCSM as a valid publication only as long as all statements in the guidelines on ethical publishing remain true;if any of the aforementioned statements ceases to be true, the authors have a duty to notify the editors of JCSM as soon as possible so that the information available online can be updated and/or the manuscript can be withdrawn.

Entities:  

Year:  2010        PMID: 21475697      PMCID: PMC3060648          DOI: 10.1007/s13539-010-0003-5

Source DB:  PubMed          Journal:  J Cachexia Sarcopenia Muscle        ISSN: 2190-5991            Impact factor:   12.910


The Journal of Cachexia, Sarcopenia and Muscle (JCSM) is a peer-reviewed international journal dedicated to publishing materials that are related to cachexia and sarcopenia as well as to body composition and its physiological and pathophysiological changes during the life span and in different illnesses from all fields of the life sciences. We share the view that academic publishing depends, to a great extent, on trust between authors, peer reviewers, editors, and the public [1]. Academic publications are made in an environment of competing interests that may be commercial, intellectual, and/or political in nature. Some of these issues create conflicts of interest. In this context, the Editors of JCSM see it as their duty to promote transparency and research integrity. Therefore, all authors wishing to publish in JCSM are required to certify that they comply with the guidelines of publishing in JCSM outlined below. This should be done by stating as part of the published manuscript that “All authors of this manuscript comply with the guidelines of ethical authorship and publishing in the Journal of Cachexia, Sarcopenia and Muscle”, providing reference to these guidelines by referencing this article. Specifically, the corresponding author, on behalf of all co-authors, certifies that all authors listed on the manuscript have approved its submission and publication as provided to JCSM; certifies that no person who has a right to be recognized as author has been omitted from the list of authors; certifies that each author has made an independent material contribution to the work submitted for publication; certifies that the submitted work is original and is neither under consideration elsewhere nor has it been published previously in whole or in part other than in abstract form; certifies that for all original research work, the relevant bodies such as institutional review boards or ethics committees have approved the studies. This rule is not applicable for review articles or editorial comments that give reference to other people’s work; certifies that all conflicts of interest, financial or otherwise, that may affect the authors’ ability to present data objectively, have been duly declared in the manuscript; and understands that the manuscript in its published form will be maintained on the servers of JCSM as a valid publication only as long as all statements in the guidelines on ethical publishing remain true. If any of the aforementioned statements ceases to be true, the authors have a duty to notify the Editors of JCSM as soon as possible so that that the information available online can be updated and/or the manuscript can be withdrawn. We are happy to be able to start this new journal—we feel that there is a great need for it as there is a major unmet need for the medical problems it concerns. Despite these happy thoughts, we recognize that the world is not free of scientific misconduct that can come in many ways. The Editors of JCSM aim to keep a close eye on these issues. We want to take a lead in identifying, notifying, investigating, and reporting all occurrences of scientific misconduct, and we will withdraw papers if significant problems come to our attention. This shall be no surprise to anyone when it has to occur and hence, we request that these guidelines are cited in each article published in JCSM. As stated before, academic publishing is built on trust—we want JCSM to be a trusted source of best available scientific knowledge in the field. We hope that, together, we can achieve this objective and our journal can succeed in this ambition.
  1 in total

1.  Best Practice Guidelines on Publication Ethics: a publisher's perspective.

Authors:  Chris Graf; Elizabeth Wager; Alyson Bowman; Suzan Fiack; Diane Scott-Lichter; Andrew Robinson
Journal:  Int J Clin Pract Suppl       Date:  2007-01
  1 in total
  57 in total

1.  The selective androgen receptor modulator GTx-024 (enobosarm) improves lean body mass and physical function in healthy elderly men and postmenopausal women: results of a double-blind, placebo-controlled phase II trial.

Authors:  James T Dalton; Kester G Barnette; Casey E Bohl; Michael L Hancock; Domingo Rodriguez; Shontelle T Dodson; Ronald A Morton; Mitchell S Steiner
Journal:  J Cachexia Sarcopenia Muscle       Date:  2011-08-02       Impact factor: 12.910

2.  Clinical use of amino acids as dietary supplement: pros and cons.

Authors:  Francesco S Dioguardi
Journal:  J Cachexia Sarcopenia Muscle       Date:  2011-06-11       Impact factor: 12.910

3.  Intramyocellular lipid droplets increase with progression of cachexia in cancer patients.

Authors:  Nathan A Stephens; Richard J E Skipworth; Alisdair J Macdonald; Carolyn A Greig; James A Ross; Kenneth C H Fearon
Journal:  J Cachexia Sarcopenia Muscle       Date:  2011-05-31       Impact factor: 12.910

4.  Combined approach to counteract experimental cancer cachexia: eicosapentaenoic acid and training exercise.

Authors:  Fabio Penna; Silvia Busquets; Fabrizio Pin; Miriam Toledo; Francesco M Baccino; Francisco J López-Soriano; Paola Costelli; Josep M Argilés
Journal:  J Cachexia Sarcopenia Muscle       Date:  2011-05-11       Impact factor: 12.910

5.  Age- and gender-dependent values of skeletal muscle mass in healthy children and adolescents.

Authors:  Colin E Webber; Ronald D Barr
Journal:  J Cachexia Sarcopenia Muscle       Date:  2011-10-30       Impact factor: 12.910

6.  An overview of sarcopenia: facts and numbers on prevalence and clinical impact.

Authors:  Stephan von Haehling; John E Morley; Stefan D Anker
Journal:  J Cachexia Sarcopenia Muscle       Date:  2010-12-17       Impact factor: 12.910

7.  Protective effects of an anti-melanocortin-4 receptor scFv derivative in lipopolysaccharide-induced cachexia in rats.

Authors:  Jean-Christophe Peter; Hélène Rossez; Marjorie Weckering; Géraldine Zipfel; Anne-Catherine Lecourt; Joshua B Owen; William A Banks; Karl G Hofbauer
Journal:  J Cachexia Sarcopenia Muscle       Date:  2012-08-22       Impact factor: 12.910

8.  Is there a genetic cause of appetite loss?-an explorative study in 1,853 cancer patients.

Authors:  Tora S Solheim; Peter M Fayers; Torill Fladvad; Ben Tan; Frank Skorpen; Kenneth Fearon; Vickie E Baracos; Pål Klepstad; Florian Strasser; Stein Kaasa
Journal:  J Cachexia Sarcopenia Muscle       Date:  2012-04-26       Impact factor: 12.910

9.  Finding good biomarkers for sarcopenia.

Authors:  Gesine Scharf; Joerg Heineke
Journal:  J Cachexia Sarcopenia Muscle       Date:  2012-08-02       Impact factor: 12.910

10.  Biomarkers of sarcopenia in clinical trials-recommendations from the International Working Group on Sarcopenia.

Authors:  Matteo Cesari; Roger A Fielding; Marco Pahor; Bret Goodpaster; Marc Hellerstein; Gabor A van Kan; Stefan D Anker; Seward Rutkove; J Willem Vrijbloed; Maria Isaac; Yves Rolland; Christine M'rini; Mylène Aubertin-Leheudre; Jesse M Cedarbaum; Mauro Zamboni; Cornell C Sieber; Didier Laurent; William J Evans; Ronenn Roubenoff; John E Morley; Bruno Vellas
Journal:  J Cachexia Sarcopenia Muscle       Date:  2012-08-03       Impact factor: 12.910

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.